Although doxorubicin largely induces SAT1 expression at physiological concentrations as demonstrated in TM98 and NCI-60 cell lines, doxorubicin decreased plasma and urine diacetylspermine in TM99, which coincided with decreasing tumor size. The gene discussed is SAT1; the disease is neoplasm.